Key result
Metabolic syndrome affects ~28% of pediatric kidney recipients but shows no association with LVH.
Why the study?
The prevalence of obesity and metabolic syndrome and their association with cardiovascular outcomes in pediatric kidney transplant recipients needed to be evaluated in a single center in India.
Cross-Sectional (n=32)
No
Answers are grounded in this paper and cite their sources.
Metabolic syndrome is common in pediatric kidney transplant recipients, primarily driven by post-transplant weight gain, but was not independently associated with left ventricular hypertrophy in this cohort.
BACKGROUND: The study aimed to determine the prevalence of obesity and metabolic syndrome (MS) and analyze the cardiovascular outcomes in pediatric kidney transplant recipients from a single center in India. METHODS: Determinants of MS, including weight, height, body mass index (BMI), blood pressure, fasting blood sugar, triglyceride, and high-density lipoprotein (HDL) were collected for children with at least 1 year follow-up post-transplant. Cardiovascular outcomes were hypertension, left ventricular hypertrophy (LVH), and carotid intima medial thickness (cIMT). Muscle strength was evaluated by measuring hand grip strength (HGS). Diagnosis of obesity and MS was done by applying recommendations from the Pediatric Renal Nutrition Task Force. RESULTS: The median age of the cohort (32 recipients, 71% male) was 14.0 years (IQR 12.0, 15.9). At a median 21.5 months (IQR 17, 37.5) after first kidney transplantation, 9 (28.1%) had MS. Hypertriglyceridemia was present in 17 children (53.1%), low HDL cholesterol in 10 (31.2%), hypertension in 22 (68.8%), and fasting hyperglycemia in 7 (21.9%). The ΔBMI height-age Z-score was significantly higher in the MS group (p = 0.003). There was no difference in eGFR, LVMI, Triglyceride index and HGS between the MS and Non-MS groups. In multivariate regression analysis, the ΔBMI height-age Z-score and Acute rejection were independent predictors of MS and LVH, respectively. MS was not an independent predictor of LVH. All patients had elevated cIMT. CONCLUSION: MS was found in about a third of the cohort. Graft function and LVH were similar between the groups. Post-transplant weight gain was a key determinant of MS.
No takes yet. Share an insight, caveat, or question.
Saha et al. (2026) conducted a cross-sectional in Pediatric kidney transplant (n=32). Metabolic syndrome vs. No metabolic syndrome was evaluated on Cardiovascular outcomes (hypertension, left ventricular hypertrophy, and carotid intima medial thickness). Metabolic syndrome was present in 28.1% of pediatric kidney transplant recipients, but graft function and left ventricular hypertrophy were similar between those with and without metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: